comparemela.com

Latest Breaking News On - Michael pryce jones - Page 8 : comparemela.com

Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout

Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.

Johnson & Johnson CEO s pay increase questioned by investors concerned with legal costs of opioid lawsuits

Johnson & Johnson CEO s pay increase questioned by investors concerned with legal costs of opioid lawsuits
theglobeandmail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobeandmail.com Daily Mail and Mail on Sunday newspapers.

Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout

Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout

Exclusive: J&J CEO pay irks investors upset with opioid lawsuits fallout
channelnewsasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from channelnewsasia.com Daily Mail and Mail on Sunday newspapers.

AmerisourceBergen rewards CEO despite the ravages of the opioid crisis

Adobe You can file this under, “What opioid crisis?” In one of the more startling examples of tin-ear syndrome, AmerisourceBergen wants its shareholders to bless a $14.3 million pay package for chief executive officer Steven Collis. Not only is this a hefty amount of money, but it represents a 26% boost over the previous year. The pharmaceutical wholesaler can act so generously thanks to a tricky maneuver: excluding the cost of legal settlements for evaluating executives. For those not tracking the sprawling opioid litigation around the U.S., the company is expected to pay $6.6 billion to compensate communities for the cost of grappling with substance use disorder, prescription drug overdoses, and deaths.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.